This compound binds with high affinity and selectivity to the human glucocorticoid receptor, inhibits in vitro cytokine secretion from peripheral blood mononuclear cells, blocks T-cell proliferation and, when topically administered in vivo in two models of contact dermatitis, has strong anti-inflammatory activity. Here, NR3C1 is linked to contact dermatitis.